|
SCAND1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.877240E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.735100E-03 |
| Normal-vs-Stage2 |
2.579500E-03 |
| Normal-vs-Stage3 |
2.057800E-02 |
| Normal-vs-Stage4 |
8.914000E-02 |
| Stage1-vs-Stage2 |
1.437040E-01 |
| Stage1-vs-Stage3 |
9.368800E-01 |
| Stage1-vs-Stage4 |
7.522600E-01 |
| Stage2-vs-Stage3 |
1.551950E-01 |
| Stage2-vs-Stage4 |
1.521590E-01 |
| Stage3-vs-Stage4 |
8.061200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.080300E-03 |
| Normal-vs-AfricanAmerican |
2.068000E-02 |
| Normal-vs-Asian |
1.058380E-01 |
| Caucasian-vs-AfricanAmerican |
7.067000E-01 |
| Caucasian-vs-Asian |
6.804200E-01 |
| AfricanAmerican-vs-Asian |
5.350200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.581050E-03 |
| Normal-vs-Female |
5.541000E-03 |
| Male-vs-Female |
3.081000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.361400E-03 |
| Normal-vs-Age(41-60Yrs) |
1.404430E-02 |
| Normal-vs-Age(61-80Yrs) |
1.130080E-02 |
| Normal-vs-Age(81-100Yrs) |
6.467400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.545800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.288000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.136800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.366000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.488600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.627000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.729700E-02 |
| Classical-VS-Follicular |
1.414590E-01 |
| Classical-VS-Other |
3.044400E-01 |
| Classical-VS-Normal |
8.879200E-03 |
| Tall-VS-Follicular |
6.563000E-03 |
| Tall-VS-Other |
1.756000E-02 |
| Tall-VS-Normal |
6.423800E-01 |
| Follicular-VS-Other |
6.168200E-01 |
| Follicular-VS-Normal |
1.395140E-03 |
| Other-VS-Normal |
1.575790E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.830500E-04 |
| Normal-vs-N1 |
2.609100E-04 |
| N0-vs-N1 |
9.623600E-02 |
|
|
